Sjöblom T

A human pan-disease blood atlas of the circulating proteome.

Álvez MB, Bergström S, Kenrick J, ..., Edfors F, Uhlén M

Science (New York, N.Y.) 390 (6779) eadx2678 [2025-12-18; online 2025-12-18]

Adil Mardinoglu SciLifeLab Fellow

Tissue-resident microbiota impacts colorectal cancer progression and prognosis.

Shi Z, Ren H, Lin C, ..., Sjöblom T, Zhong H

Nat Commun 17 (1) 346 [2025-12-07; online 2025-12-07]

A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.

Soussi T, Kundu S, Gerbaud P, ..., Sjöblom T, Baliakas P

Br. J. Haematol. 207 (3) 1118-1121 [2025-09-00; online 2025-07-07]

Precision Omics Initiative Sweden (PROMISE) will integrate research with healthcare.

Kämpe A, Gudmundsson S, Walsh CP, ..., Lindstrand A, Lappalainen T

Nat. Med. 31 (6) 1730-1732 [2025-06-00; online 2025-04-05]

Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib.

Zhang X, Rameika N, Zhong L, ..., Globisch D, Sjöblom T

EBioMedicine 109 (-) 105368 [2024-11-00; online 2024-10-04]

Prognostic genome and transcriptome signatures in colorectal cancers.

Nunes L, Li F, Wu M, ..., Lin C, Sjöblom T

Nature 633 (8028) 137-146 [2024-09-00; online 2024-08-07]

Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma.

Sandberg E, Nunes L, Edqvist PH, ..., Landegren U, Sjöblom T

Cancers (Basel) 16 (3) - [2024-01-27; online 2024-01-27]

Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma

Sandberg E, Nunes L, Edqvist PH, ..., Landegren U, Sjöblom T

- - (-) - [2024-01-11; online 2024-01-11]

Loss of CYP2D6 sensitizes hepatocellular carcinomas and neuroblastomas to talazoparib

Sjöblom T, Zhang X, Rameika N, ..., Heim M, Globisch D

- - (-) - [2023-08-21; online 2023-08-21]

Next generation pan-cancer blood proteome profiling using proximity extension assay.

Álvez MB, Edfors F, von Feilitzen K, ..., Fagerberg L, Uhlén M

Nat Commun 14 (1) 4308 [2023-07-18; online 2023-07-18]

Adil Mardinoglu DDLS Fellow Fredrik Edfors SciLifeLab Fellow

Rigorous software pipeline for clinical somatic mutation analyses of solid tumors

Stoimenov I, Rashyna M, Adlerteg T, ..., Cheong I, Sjöblom T

- - (-) - [2023-06-14; online 2023-06-14]

Prognostic whole-genome and transcriptome signatures in colorectal cancers

Nunes L, Li F, Wu M, ..., Lin C, Sjöblom T

- - (-) - [2023-03-30; online 2023-03-30]

Next generation pan-cancer blood proteome profiling using proximity extension assay

Uhlen M, Álvez MB, Edfors F, ..., Pontén F, Fagerberg L

- - (-) - [2022-11-01; online 2022-11-01]

Adil Mardinoglu DDLS Fellow Fredrik Edfors SciLifeLab Fellow

Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.

Gyllensten U, Hedlund-Lindberg J, Svensson J, ..., Åberg M, Enroth S

Cancers (Basel) 14 (7) - [2022-03-30; online 2022-03-30]

Author Correction: Targeted sequencing reveals the somatic mutation landscape in a Swedish breast cancer cohort.

Mathioudaki A, Ljungström V, Melin M, ..., Sjöblom T, Lindblad-Toh K

Sci Rep 11 (1) 5310 [2021-03-01; online 2021-03-01]

Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy.

Zhang X, Sjöblom T

Pharmaceuticals (Basel, Switzerland) 14 (1) - [2021-01-13; online 2021-01-13]

Targeted sequencing reveals the somatic mutation landscape in a Swedish breast cancer cohort.

Mathioudaki A, Ljungström V, Melin M, ..., Sjöblom T, Lindblad-Toh K

Sci Rep 10 (1) 19304 [2020-11-09; online 2020-11-09]

Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N-Acetyltransferase NAT2.

Conway LP, Rendo V, Correia MSP, ..., Sjöblom T, Globisch D

Angew. Chem. Int. Ed. Engl. 59 (34) 14342-14346 [2020-08-17; online 2020-07-08]

Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine ‐Acetyltransferase NAT2

Conway LP, Rendo V, Correia MSP, ..., Sjöblom T, Globisch D

Angewandte Chemie 132 (34) 14448-14452 [2020-08-17; online 2020-07-08]

Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis.

Nunes L, Aasebø K, Mathot L, ..., Sjöblom T, Glimelius B

Acta Oncol 59 (4) 417-426 [2020-04-00; online 2020-01-10]

Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy.

Rendo V, Stoimenov I, Mateus A, ..., Cheong I, Sjöblom T

Nat Commun 11 (1) 1308 [2020-03-11; online 2020-03-11]